Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).

about

Value of non-identified ANCA (non-PR3, non-MPO) in the diagnosis of granulomatosis with polyangiitis (Wegener's granulomatosis).

Item

http://www.wikidata.org/entity/Q39032392

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@en

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@nl

type

Item

label

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@en

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@nl

prefLabel

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@en

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@nl

P1476

Value of non-identified ANCA ( ...... is (Wegener's granulomatosis).

@en

P2093

Annick Ocmant

http://www.w3.org/2001/XMLSchema#string

Frédéric Vandergheynst

http://www.w3.org/2001/XMLSchema#string

Muhammad S Soyfoo

http://www.w3.org/2001/XMLSchema#string

Mélanie Givaudan

http://www.w3.org/2001/XMLSchema#string

Patrick Stordeur

http://www.w3.org/2001/XMLSchema#string

Valérie Gangji

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features.

Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.

Current and emerging techniques for ANCA detection in vasculitis.

Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.

Antineutrophil cytoplasmic antibodies.

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Pulmonary-renal syndromes.

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17843286.2016.1275374

http://www.w3.org/2001/XMLSchema#string

P50

Christian Melot

P577

2017-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28067125

http://www.w3.org/2001/XMLSchema#string